533 related articles for article (PubMed ID: 31575676)
1. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.
Rambow F; Marine JC; Goding CR
Genes Dev; 2019 Oct; 33(19-20):1295-1318. PubMed ID: 31575676
[TBL] [Abstract][Full Text] [Related]
2. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
4. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
[TBL] [Abstract][Full Text] [Related]
5. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
6. Microenvironment-derived factors driving metastatic plasticity in melanoma.
Kim IS; Heilmann S; Kansler ER; Zhang Y; Zimmer M; Ratnakumar K; Bowman RL; Simon-Vermot T; Fennell M; Garippa R; Lu L; Lee W; Hollmann T; Xavier JB; White RM
Nat Commun; 2017 Feb; 8():14343. PubMed ID: 28181494
[TBL] [Abstract][Full Text] [Related]
7. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
[TBL] [Abstract][Full Text] [Related]
8. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Ballotti R; Cheli Y; Bertolotto C
Mol Cancer; 2020 Dec; 19(1):170. PubMed ID: 33276788
[TBL] [Abstract][Full Text] [Related]
9. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
Vivas-García Y; Falletta P; Liebing J; Louphrasitthiphol P; Feng Y; Chauhan J; Scott DA; Glodde N; Chocarro-Calvo A; Bonham S; Osterman AL; Fischer R; Ronai Z; García-Jiménez C; Hölzel M; Goding CR
Mol Cell; 2020 Jan; 77(1):120-137.e9. PubMed ID: 31733993
[TBL] [Abstract][Full Text] [Related]
10. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Kaur A; Webster MR; Marchbank K; Behera R; Ndoye A; Kugel CH; Dang VM; Appleton J; O'Connell MP; Cheng P; Valiga AA; Morissette R; McDonnell NB; Ferrucci L; Kossenkov AV; Meeth K; Tang HY; Yin X; Wood WH; Lehrmann E; Becker KG; Flaherty KT; Frederick DT; Wargo JA; Cooper ZA; Tetzlaff MT; Hudgens C; Aird KM; Zhang R; Xu X; Liu Q; Bartlett E; Karakousis G; Eroglu Z; Lo RS; Chan M; Menzies AM; Long GV; Johnson DB; Sosman J; Schilling B; Schadendorf D; Speicher DW; Bosenberg M; Ribas A; Weeraratna AT
Nature; 2016 Apr; 532(7598):250-4. PubMed ID: 27042933
[TBL] [Abstract][Full Text] [Related]
11. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
13. The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.
Phung B; Cieśla M; Sanna A; Guzzi N; Beneventi G; Cao Thi Ngoc P; Lauss M; Cabrita R; Cordero E; Bosch A; Rosengren F; Häkkinen J; Griewank K; Paschen A; Harbst K; Olsson H; Ingvar C; Carneiro A; Tsao H; Schadendorf D; Pietras K; Bellodi C; Jönsson G
Cell Rep; 2019 Jun; 27(12):3573-3586.e7. PubMed ID: 31216476
[TBL] [Abstract][Full Text] [Related]
14. MITF in melanoma: mechanisms behind its expression and activity.
Hartman ML; Czyz M
Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
[TBL] [Abstract][Full Text] [Related]
15. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.
Costa FF; Seftor EA; Bischof JM; Kirschmann DA; Strizzi L; Arndt K; Bonaldo Mde F; Soares MB; Hendrix MJ
Epigenomics; 2009 Dec; 1(2):387-98. PubMed ID: 20495621
[TBL] [Abstract][Full Text] [Related]
16. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming to developmental plasticity in cancer stem cells.
O'Brien-Ball C; Biddle A
Dev Biol; 2017 Oct; 430(2):266-274. PubMed ID: 28774727
[TBL] [Abstract][Full Text] [Related]
18. The MITF regulatory network in melanoma.
Chauhan JS; Hölzel M; Lambert JP; Buffa FM; Goding CR
Pigment Cell Melanoma Res; 2022 Sep; 35(5):517-533. PubMed ID: 35771179
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis.
Hölzel M; Tüting T
Trends Immunol; 2016 Jun; 37(6):364-374. PubMed ID: 27151281
[TBL] [Abstract][Full Text] [Related]
20. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA.
Bell RE; Levy C
Pigment Cell Melanoma Res; 2011 Dec; 24(6):1088-106. PubMed ID: 22004179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]